|
Cancer related pathologs. Representative disease is shown for each clone. * RTPS6.3 (representative transcript protein set 6.3) cluster representative transcriptional unit (TU) of the FANTOM2 clone set. OMIM status: 1 = gene present in OMIM with a reported disease; 2 = gene present in OMIM with different disease association or without disease; 3 = gene not present in OMIM. |
|||||
| Disease |
FANTOM ID |
DDBJ accession |
Gene name |
Disease relationship |
OMIM status |
|
|
|||||
| CANCER |
|||||
| Diagnosis |
|||||
| 1110013A16* |
AK003650 |
Squamous cell carcinoma antigen 2 |
Squamous cell carcinoma |
1 |
|
| 1300012C15* |
AK004970 |
Cargo selection protein tip47 |
Gynecologic malignancies |
2 |
|
| 1600002M22* |
AK005400 |
Pregnancy-specific beta 1-glycoprotein |
Trophoblastic disease, tumour marker |
1 |
|
| 1810011L16* |
AK007436 |
Adamts-9 precursor |
Hereditary renal tumors |
3 |
|
| 2310046E09 |
AK009843 |
Pancreatic secretory granule membrane major glycoprotein gp2 precursor |
Chronic lymphocytic leukemia |
2 |
|
| 2600013I19* |
AK011199 |
Diphthamide biosynthesis protein-2 |
Prognosis of neoplastic diseases |
2 |
|
| 4631401E18* |
AK019470 |
Udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyl Transferase 7 |
Colorectal carcinoma |
2 |
|
| 4930435F02 |
AK019597 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 |
Breast cancer |
3 |
|
| 4932411D20* |
AK029960 |
Ctcl tumor antigen se2-2 |
T-cell based immunotherapy |
3 |
|
| 5330423N11* |
AK077331 |
Melastatin 2 |
Cutaneous malignant melanoma |
3 |
|
| 9130023H10* |
AK033603 |
Mlze |
Melanoma |
3 |
|
| 9130413M24* |
AK078964 |
Ctcl tumor antigen se57-1 |
T-cell based immunotherapy |
3 |
|
| 9330156N18* |
AK034104 |
Desmoglein 1 precursor |
Paraneoplastic pemphigus |
2 |
|
| A030012E10* |
AK037235 |
Serine protease desc1 precursor |
Squamous cell carcinoma |
3 |
|
| A230060D07* |
AK038754 |
Reverse transcriptase-like protein |
Chronic myelogenous leukemia |
3 |
|
| A430037M23 |
AK039975 |
Dipeptidyl-peptidase iii |
Endometrial neoplasms |
2 |
|
| A630051G17 |
AK080312 |
Meningioma-expressed antigen 6/11 |
Meningioma and glioma |
1 |
|
| E130307D12* |
AK087504 |
Scaffold attachment Factor b |
Breast cancer |
1 |
|
| G430124K07* |
AK090101 |
Restricted expression proliferation associated protein 100 |
Lung carcinoma |
3 |
|
| Pathophysiology |
|||||
| 0610006O14 |
AK002260 |
Vacuolar proton-atpase subunit atp6h |
Melanoma |
2 |
|
| 0610008P16* |
AK002360 |
Hp33 protein |
Hepatocellular carcinoma |
3 |
|
| 1110068E08* |
AK004405 |
Ku70-binding protein |
Gliomas |
3 |
|
| 1200003O15* |
AK004587 |
Proto-oncogene tyrosine-protein kinase fes/fps |
Leukaemia |
1 |
|
| 1500012D09 |
AK005230 |
Ras-related protein rab-2 |
Nasopharyngeal carcinoma |
1 |
|
| 1700001P03* |
AK005620 |
Homeobox transcription factor |
Colon cancer |
1 |
|
| 1700006L01 |
Smac protein, mitochondrial precursor |
Multiple myeloma |
2 |
||
| 1700012B18* |
AK005892 |
Pregnancy-induced growth inhibitor |
Breast cancer |
3 |
|
| 1700045I19* |
AK006700 |
Hsd-4 protein |
Prostate cancer |
2 |
|
| 1810017F10* |
AK007525 |
Beta-casein-like protein |
Tumour-associated antigen |
3 |
|
| 2010003F10* |
AK008064 |
Transmembrane 4 superfamily, member 5 |
Pancreatic cancer |
1 |
|
| 2210006M16* |
AK008663 |
Gasdermin |
Human gastric cancer cells |
3 |
|
| 2210007N23 |
AK019050 |
Ca11 protein homolog |
Gastric carcinogenesis |
1 |
|
| 2210412D05 |
AK008907 |
Rho guanine nucleotide exchange factor 5 |
Acute myeloid leukaemia |
1 |
|
| 2210414K06 |
AK008928 |
Nesh |
Cell metastasis and malignant transformation |
2 |
|
| 2310016C08* |
AK009377 |
Hypoxia-inducible protein 2 |
Cervix cancer |
3 |
|
| 2510002J07* |
AK010891 |
1-acyl-sn-glycerol-3-phosphate acyltransferase beta |
Cancers and inflammation-associated diseases. |
2 |
|
| 2610002I10 |
AK011289 |
C-myc target jpo1 |
Tumourigenesis |
3 |
|
| 2610005L07 |
AK011323 |
Cadherin |
Cancer development |
1 |
|
| 2700048G21* |
AK012392 |
Antigen ny-co-8 |
Colon cancer antigen |
3 |
|
| 2810411G23 |
AK013085 |
Tumor protein d54 |
Breast cancer |
1 |
|
| 2810425C21* |
AK013153 |
Death domain of death-associated protein kinase 1 |
Non-small cell lung cancer |
2 |
|
| 2810449N18* |
AK013316 |
Sirtuin 6 |
Thyroid carcinoma |
2 |
|
| 2900009D12 |
AK013503 |
Succinate dehydrogenase |
Hereditary paraganglioma |
1 |
|
| 4432412E01* |
AK014491 |
X-ray repair cross-complementing protein 3 |
Bladder-cancer |
2 |
|
| 4631410F01 |
AK028459 |
Adamts-12 precursor |
Gastric carcinomas |
3 |
|
| 4732440A06* |
AK028704 |
Calcium-activated chloride channel-2 |
Breast cancer, metastasis |
2 |
|
| 4930500E24* |
AK019661 |
Gas-2 related protein on chromosome 22 |
Central nervous system tumours |
3 |
|
| 4932436B18* |
AK030081 |
Pms1 protein homolog 1 |
Prostate cancer |
1 |
|
| 4933405E14* |
AK016662 |
Serologically defined colon cancer antigen 1 |
Tumour suppressor |
3 |
|
| 4933409E02* |
AK016751 |
Retinoblastoma-associated protein rap140 |
Colon cancer cell line |
3 |
|
| 5430417G24* |
AK030670 |
Headpin serine proteinase inhibitor |
Squamous cell carcinoma |
1 |
|
| 5630400A09* |
AK030708 |
P63 protein |
Basal cell and squamous cell carcinomas |
1 |
|
| 5730484M20* |
AK077629 |
Cell cycle checkpoint protein chfr |
Lung cancer |
1 |
|
| 6430531D06* |
AK032385 |
Elks |
Capillary thyroid carcinoma |
1 |
|
| 6430587E11 |
AK032541 |
Copine vii |
Breast cancer |
1 |
|
| 6820401K01* |
AK033012 |
Npat |
Cancer development |
2 |
|
| 9330137N20 |
AK079068 |
Hepatic leukemia factor |
Lymphoblastic leukaemia |
1 |
|
| 9330200A01* |
AK034492 |
Ubiquitin specific protease |
Squamous non-small cell lung carcinoma |
2 |
|
| A130080E24* |
AK038118 |
C-myb protein |
Colon tumour |
3 |
|
| A430025E01* |
AK039888 |
P68 RNA helicase |
Colorectal tumours |
2 |
|
| A430075F05 |
AK040185 |
Lipoma preferred partner |
Acute myeloid leukaemia |
1 |
|
| A730042E07 |
AK042943 |
Serine/threonine protein phosphatase 2a, 72/130 kda regulatory subunit B |
Melanoma |
2 |
|
| A830098D13* |
AK044188 |
Megacaryocytic acute leukemia protein, isoform i |
Acute megakaryoblastic leukemias |
1 |
|
| A930033B01 |
AK020920 |
Graf |
Hematopoeitic disorders |
1 |
|
| B130017M24 |
AK044984 |
Hepatocellular carcinoma autoantigen |
Hepatocellular carcinoma |
3 |
|
| B230314N17 |
AK045848 |
Deleted in lung and esophageal cancer 1 |
Carcinogenesis |
1 |
|
| B930026D14* |
AK047144 |
Myc box dependent interacting protein 1 |
Prostate carcinoma |
3 |
|
| B930095M03* |
AK081171 |
Frat2 |
Gastric cancer |
1 |
|
| C130050F24* |
AK048341 |
Ranbp7/importin 7 |
Colorectal carcinoma |
2 |
|
| C130062I06* |
AK048462 |
Fibrillarin |
Hepatocellular carcinoma |
1 |
|
| C230012L01 |
AK048706 |
Androgen-induced prostate proliferative shutoff associated protein |
Prostate cancer |
1 |
|
| C630001O15 |
AK049821 |
Malt1 |
MALT lymphoma |
1 |
|
| D330038I09 |
AK052361 |
10-formyltetrahydrofolate dehydrogenase |
Tumour cells |
2 |
|
| E030001H09* |
AK086788 |
Phd finger protein 3 |
Glioblastoma multiforme |
1 |
|
| E030027H19* |
AK087108 |
Cub domain containing Protein 1 |
Human colorectal cancer |
3 |
|
| E230037B21 |
AK054229 |
Vault poly(adp-ribose) polymerase |
Several tumour types |
3 |
|
| F630110I03 |
AK089273 |
Matrix metalloproteinase-25 precursor |
Colon carcinomas or brain tumours |
3 |
|
| F730035A01 |
AK089461 |
Swi/snf complex 170 kda subunit |
Malignant rhabdoid tumours |
1 |
|
| G630018E19* |
AK090207 |
Prostate cancer overexpressed gene 1 |
Prostate cancer |
1 |
|
| G630034H08* |
AK090280 |
Transcriptional repressor scratch |
Small cell lung cancer |
3 |
|
| Treatment |
|||||
| 1100001P14 |
AK075618 |
Beta-tubulin class iva isotype |
Human colon adenocarcinoma |
3 |
|
| 1200012D01* |
AK004723 |
Magic roundabout |
Angiogenesis |
3 |
|
| 1810010L20 |
AK075773 |
Pituitary tumor-transforming gene 1 protein-interacting protein |
Pituitary adenomas |
2 |
|
| 2310039D24* |
AK009689 |
Carboxylesterase |
Solid tumours |
1 |
|
| 2600009M07 |
AK011174 |
Polyamine modulated factor-1 |
Antineoplastic activity |
3 |
|
| 2810459H04 |
AK013366 |
Thrombospondin |
Angiogenesis |
1 |
|
| 3010033I09* |
AK019405 |
Alex1 |
Tumours originating from epithelial tissue |
1 |
|
| 5730405M22* |
AK077421 |
Phosphoprotein enriched in astrocytes 15 |
Glioma |
2 |
|
| 6030493E19 |
AK031701 |
Melanoma antigen p15 |
Melanoma |
1 |
|
| 6230424I22* |
AK031785 |
NUCLEAR MATRIX PROTEIN p84 |
Tumor suppression |
2 |
|
| A730016J02 |
AK042696 |
Acetyltransferase tubedown-1 |
Vascular and haematopoietic development |
3 |
|
| B130023J22 |
AK045057 |
Greb1b |
Breast cancer |
3 |
|
| C920008O22 |
AK050594 |
Retinoblastoma-binding protein 1 |
Breast cancer |
2 |
|
| D030050C19 |
AK083587 |
Chronic myelogenous leukemia tumor antigen 66 |
Leukemias and tumour cell lines |
1 |
|
| D630010E08* |
AK052639 |
Carbonic anhydrase xii precursor |
Cancer tumour cells |
1 |
|
| D830007E07* |
AK052857 |
Inositol hexakisphosphate kinase 3 |
Ovarian cancer |
2 |
|
Silva et al. BMC Genomics 2004 5:28 doi:10.1186/1471-2164-5-28 |
|||||